Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth

Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial

(2018) Cheol Min Shin et al.   CLINICAL NUTRITION

Cancer immunotherapy using checkpoint blockade

(2018) Antoni Ribas et al.   SCIENCE

New windows open for immunotherapy in lung cancer

(2018) Lizza Hendriks et al.   NATURE

The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint

(2017) Qingshui Wang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Down-regulation of histone deacetylase 4, −5 and −6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin

(2017) Yukiko Oya et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Adsorption of galloyl catechin aggregates significantly modulates membrane mechanics in the absence of biochemical cues

(2017) Takahisa Matsuzaki et al.   PHYSICAL CHEMISTRY CHEMICAL PHYSICS

Coinhibitory Pathways in Immunotherapy for Cancer

(2016) Susanne H. Baumeister et al.   Annual Review of Immunology

Apigenin inhibits the inducible expression of programmed death ligand 1 by human and mouse mammary carcinoma cells

(2016) Melanie R. Power Coombs et al.   CANCER LETTERS

Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins

(2016) Masami Suganuma et al.   MOLECULES

Potentiating the antitumour response of CD8+ T cells by modulating cholesterol metabolism

(2016) Wei Yang et al.   NATURE

BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression

(2016) Hengrui Zhu et al.   Cell Reports

Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer

(2015) Kristin J. Lastwika et al.   CANCER RESEARCH

Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds

(2014) Hirota Fujiki et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Mechanism-based inhibition of cancer metastasis with (−)-epigallocatechin gallate

(2013) Atsushi Takahashi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells

(2013) I. B. Barsoum et al.   CANCER RESEARCH

Regulating miRNA by Natural Agents as a New Strategy for Cancer Treatment

(2013) Sajiv Sethi et al.   CURRENT DRUG TARGETS

Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors

(2013) E. A. Akbay et al.   Cancer Discovery

New cancer treatment strategy using combination of green tea catechins and anticancer drugs

(2010) Masami Suganuma et al.   CANCER SCIENCE

Indoleamine 2,3-Dioxygenase, an Immunomodulatory Protein, Is Suppressed by (−)-Epigallocatechin-3-gallate via Blocking of γ-Interferon-Induced JAK-PKC-δ-STAT1 Signaling in Human Oral Cancer Cells

(2009) Chieh-Wen Cheng et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Green Tea Extracts for the Prevention of Metachronous Colorectal Adenomas: A Pilot Study

(2008) M. Shimizu et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION